General procedure for the synthesis of conjugates 6a-6l: To a well stirred solution of N-alkylazidoisatins 3a-c (1 mmol) and N-propargylated 2-methyl-5-nitroimidazole 5 in an ethanol:water (85 : 15) mixture, was added CuSO 4 .5H 2 O (0.055 mmol) and sodium ascorbate (0.143 mmol). The reaction mixture was allowed to stir at room temperature for 8 h, with progress monitored via TLC. Upon completion, the reaction mixture was concentrated and extracted with ethyl acetate (2x30 mL). The combined organic layers were dried over anhydrous Na 2 SO 4 and concentrated under vacuum to afford the desired conjugates which were purified via column chromatography using an ethyl acetate: hexane (70: 30) mixture.
S2
13 C NMR (100 MHz, DMSO-d 6 ) δ 13. 1, 40.6, 41.9, 47.6, 110.4, 117.7, 122.4, 123.6, 124.9, 125.2, 138.3, 142.2, 145.4, 145.7, 150.6, 158.5, 183.3 HRMS calcd for C 17 H 15 N 7 O 4 [M+H] + 382.1219 found 382. 1231. 2, 27.2, 37.3, 42.0, 47.6, 110.9, 118.1, 122.5, 122.6, 123.5, 124.4, 124.8, 138.4, 142.0, 145.5, 150.8, 158.7, 183. 25.8, 27.2, 37.3, 42.0, 47.6, 110.9, 118.1, 122.5, 122.6, 123.5, 124.4, 124.8, 138.4, 142.0, 145.5, 150.8, 158.7, 183. 25.5, 26.5, 29.6, 37.4, 42.1, 49.8, 112.8, 119.3, 122.5, 124.0, 124.4, 127.7, 137.4, 142.0, 145.5, 145.7, 149.6, 158.3, 182.8 HRMS calcd for C 20 1, 40.7, 41.9, 47.5, 112.2, 119.1, 122.4, 124.4, 125.1, 128.0, 137.2, 142.2, 145.4, 145.7, 149.1, 158.3, 182 3, 27.8, 37.4, 42.3, 47.6, 112.7, 119.6, 122.7, 124.4, 124.5, 127.8, 137.3, 142.1, 145.6, 145.8, 149.4, 158.6, 182.6 23.8, 25.7, 29.6, 42.9, 49.5, 110.8, 112.1, 112.8, 118.4, 122.9, 124.2, 124.4, 124.9, 142.6, 144.9, 147.6, 158.8, 183 25.5, 26.5, 29.6, 37.8, 42.1, 49.8, 112.8, 119.3, 122.5, 124.0, 124.4, 127.7, 137.4, 142.0, 145.5, 145.7, 149.6, 158.3, 182.8 40.6, 41.9, 47.6, 111.4, 118.6, 122.3, 123.3, 124.7, 125.5, 138.1, 142.4, 145.9, 146 23.5, 26.4, 29.6, 42.1, 49.8, 111.8, 112.0, 112.5, 118.8, 122.6, 124.0, 124.3, 124.5, 142.0, 145.5, 147.3, 158.5, 183.3 26.2, 29.7, 36.3, 42.5, 48.9, 111.8, 118.3, 122.4, 124.1, 124.4, 127.3, 136.3, 142.1, 145.3, 146.7, 148.9, 158 36.7, 42.1, 48.7, 112.2, 120.5, 121.2, 122.6, 123.3, 124.4, 131.3, 131.6, 142.0, 143.3, 145.4, 145.8, 161.2, 179 .3 HRMS calcd for 42.0, 47.7, 111.8, 120.9, 121.9, 122.7, 124.3, 127.6, 130.3, 130.7, 141.8, 141.9, 145.6, 145.8, 161.2, 179 3, 28.1, 37.2, 42.0, 47.7, 111.8, 120.9, 121.9, 122.7, 124.3, 127.6, 130.3, 130.7, 141.8, 141.9, 145.6, 145.8, 161.2, 179 25.3, 26.6, 28.9, 37.3, 42.2, 49.4,112.4, 120.8, 121.4, 122.5, 124.6, 127.4, 130.1, 130.5, 141.4, 141.9, 145.3, 145.9, 160 48.7, 113.8, 120.3, 122.1, 122.8, 124.4, 127.7, 131.6, 133.7, 141.1, 141.9, 145.3, 145.9, 161.5, 179 3, 28.4, 36.8, 42.1, 48.7, 111.4, 120.6, 121.5, 122.3, 124.6, 127.3, 130.5, 130.9, 140.8, 141.9, 145.4, 145.9, 161.1, 179 2-(5-fluoro-1-(4-(4-((2-methyl-5-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl) 2, 24.4, 27.3, 39.1, 42.1, 49.4, 108.4, 111.6, 117.5, 121.7, 122.6, 124.1, 130.8, 139.4, 142.1, 145.5, 145.7, 158.1, 161.2, 179 3, 25.4, 27.1, 28.6, 36.2, 42.3, 48.9, 111.4, 120.1, 121.3, 122.6, 124.2, 127.2, 130.1, 130.6, 141.3, 141.9, 145.1, 145.6, 161.2, 179 4-((2-methyl-5-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)ethyl)indoline-2,3- 1-(2-(4-((2-methyl-5-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)ethyl)indoline-2,3- 4-((2-methyl-5-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)pentyl)indoline-2,3- 2-(1-(3-(4-((2-methyl-5-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3 -1-(4-(4-((2-methyl-5-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)butyl)-2-oxoindolin-3-ylidene) Grid Point Parameters 
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